R1	Has_value Arg1:T2 Arg2:T3	
R2	Has_value Arg1:T4 Arg2:T5	
R3	Has_value Arg1:T6 Arg2:T7	
*	OR T4 T6
R4	AND Arg1:T1 Arg2:T2	
R5	Subsumes Arg1:T3 Arg2:T4	
R6	Has_value Arg1:T9 Arg2:T10	
*	OR T9 T11
*	OR T12 T14 T13
*	OR T16 T17
R7	Has_value Arg1:T15 Arg2:T16	
R8	Has_qualifier Arg1:T19 Arg2:T20	
R9	Has_value Arg1:T21 Arg2:T22	
*	OR T23 T24
R10	AND Arg1:T25 Arg2:T23	
R11	Has_temporal Arg1:T23 Arg2:T26	
R12	Has_value Arg1:T29 Arg2:T30	
R13	AND Arg1:T28 Arg2:T29	
*	OR T32 T33 T34 T35
R14	AND Arg1:T37 Arg2:T32	
R15	Has_temporal Arg1:T32 Arg2:T36	
R16	Has_negation Arg1:T41 Arg2:T42	
*	OR T40 T39
R17	AND Arg1:T40 Arg2:T41	
R18	Has_qualifier Arg1:T44 Arg2:T45	
R19	Has_qualifier Arg1:T46 Arg2:T47	
*	OR T44 T46
R20	Has_value Arg1:T51 Arg2:T52	
R21	Subsumes Arg1:T53 Arg2:T51	
R22	Has_qualifier Arg1:T50 Arg2:T53	
*	OR T55 T56
R24	Subsumes Arg1:T54 Arg2:T55	
R23	Subsumes Arg1:T54 Arg2:T57	
R25	Has_temporal Arg1:T54 Arg2:T59	
*	OR T63 T64
R26	Has_value Arg1:T63 Arg2:T61	
R27	Has_value Arg1:T64 Arg2:T61	
R28	Has_temporal Arg1:T63 Arg2:T62	
R29	Has_temporal Arg1:T64 Arg2:T62	
R30	Has_temporal Arg1:T65 Arg2:T66	
*	OR T67 T68
R31	Has_qualifier Arg1:T67 Arg2:T70	
*	OR T73 T74 T75
R32	Subsumes Arg1:T72 Arg2:T73	
R33	AND Arg1:T71 Arg2:T72	
R34	Has_temporal Arg1:T77 Arg2:T78	
*	OR T80 T81
R35	Has_temporal Arg1:T77 Arg2:T80	
*	OR T85 T86
R36	Has_temporal Arg1:T82 Arg2:T79	
R37	Has_temporal Arg1:T82 Arg2:T87	
R38	Has_value Arg1:T92 Arg2:T93	
R39	Has_value Arg1:T95 Arg2:T96	
R40	Has_value Arg1:T97 Arg2:T96	
*	OR T95 T97
R41	Subsumes Arg1:T93 Arg2:T95	
R42	AND Arg1:T90 Arg2:T89	
*	OR T89 T91 T94 T92
*	OR T90 T99 T100 T105 T104
R43	AND Arg1:T100 Arg2:T101	
R44	AND Arg1:T105 Arg2:T102	
R45	AND Arg1:T104 Arg2:T103	
*	OR T107 T108
R46	Has_temporal Arg1:T107 Arg2:T109	
R47	Has_temporal Arg1:T108 Arg2:T109	
R48	Has_value Arg1:T112 Arg2:T113	
R49	AND Arg1:T111 Arg2:T110	
*	OR T110 T112
R51	Has_value Arg1:T116 Arg2:T117	
R52	Has_value Arg1:T115 Arg2:T117	
*	OR T115 T116
R50	AND Arg1:T114 Arg2:T115	
*	OR T120 T121
R53	AND Arg1:T119 Arg2:T120	
R54	Has_temporal Arg1:T120 Arg2:T122	
R55	AND Arg1:T124 Arg2:T125	
*	OR T125 T126 T127
R56	AND Arg1:T128 Arg2:T129	
R57	Subsumes Arg1:T128 Arg2:T124	
*	OR T131 T132
R58	Has_temporal Arg1:T134 Arg2:T60	
R59	Has_index Arg1:T60 Arg2:T135	
*	OR T140 T141
*	OR T138 T139
R60	Has_qualifier Arg1:T137 Arg2:T140	
R62	Has_temporal Arg1:T145 Arg2:T144	
R63	Has_mood Arg1:T147 Arg2:T146	
*	OR T145 T147
R64	Has_temporal Arg1:T124 Arg2:T148	
R65	Has_qualifier Arg1:T127 Arg2:T149	
*	OR T151 T150
R66	AND Arg1:T151 Arg2:T152	
*	OR T154 T155
R67	Has_qualifier Arg1:T154 Arg2:T156	
R68	Has_qualifier Arg1:T151 Arg2:T158	
R69	Has_mood Arg1:T160 Arg2:T159	
R70	AND Arg1:T151 Arg2:T160	
R71	multi Arg1:T159 Arg2:T161	
R72	multi Arg1:T163 Arg2:T130	
R73	Has_temporal Arg1:T163 Arg2:T162	
R74	multi Arg1:T166 Arg2:T164	
R75	multi Arg1:T166 Arg2:T165	
R76	Has_temporal Arg1:T83 Arg2:T79	
R77	Has_temporal Arg1:T84 Arg2:T79	
R78	Has_temporal Arg1:T85 Arg2:T79	
R79	Has_temporal Arg1:T83 Arg2:T87	
R80	Has_temporal Arg1:T84 Arg2:T87	
R81	Has_temporal Arg1:T85 Arg2:T87	
T1	Condition 0 19	Severe Hypertension
T2	Measurement 20 25;28 46	Grade WHO classification
T3	Value 26 27	3
T4	Measurement 48 93	Mean Sitting Diastolic Blood Pressure (MSDBP)
T5	Value 94 102	110 mmHg
T6	Measurement 110 152	Mean Sitting Systolic Blood Pressure MSSBP
T7	Value 153 161	180 mmHg
T9	Procedure 164 201	Acetylsalicyclic acid (ASA) treatment
T10	Value 202 209	>1g/day
T11	Drug 228 273	Non steroidal anti-inflammatory drug (NSAIDs)
T12	Condition 275 289	Kidney disease
T13	Condition 304 312	diabetes
T14	Condition 316 328	hypertension
T15	Measurement 330 345	Serum potassium
T16	Value 346 351	< 3.5
T17	Value 355 366	> 5.1 mEq/L
T18	Measurement 368 371	GFR
T19	Value 372 390	< 40 ml/min/1.73m2
T20	Qualifier 410 422	MDRD formula
T21	Measurement 424 437	Serum albumin
T22	Value 438 448	< 2.0mg/dL
T23	Condition 461 488	hypertensive encephalopathy
T24	Condition 492 516	cerebrovascular accident
T25	Temporal 450 457	History
T26	Temporal 520 534	any time prior
T28	Condition 568 581	heart failure
T29	Measurement 583 622	New York Heart Association (NYHA) Class
T30	Value 623 628	II-IV
T32	Condition 642 663	myocardial infarction
T33	Condition 665 689	unstable angina pectoris
T34	Condition 691 714	coronary bypass surgery
T35	Condition 723 763	percutaneous coronary intervention (PCI)
T36	Temporal 764 789	during the 6 months prior
T37	Temporal 631 638	History
T39	Condition 812 836	third degree heart block
T40	Condition 802 808;818 836	Second degree heart block
T41	Device 847 856	pacemaker
T42	Negation 837 844	without
T44	Condition 898 908	arrhythmia
T45	Qualifier 869 897	potentially life threatening
T46	Condition 924 934	arrhythmia
T47	Qualifier 912 923	symptomatic
T48	Condition 959 981	valvular heart disease
T49	Condition 983 1007	Type 1 diabetes mellitus
T50	Condition 1022 1047	Type II diabetes mellitus
T51	Measurement 1049 1079	Hemaglobin subtype A1C (HbA1C)
T52	Value 1080 1085	>11 %
T53	Qualifier 1009 1021	Uncontrolled
T54	Condition 1099 1109	malignancy
T55	Condition 1120 1128	leukemia
T56	Condition 1133 1141	lymphoma
T57	Condition 1151 1176	basal cell skin carcinoma
T59	Temporal 1178 1204	within the past five years
T60	Temporal 1250 1280	within 4 weeks prior to dosing
T61	Value 1345 1359	400 mL or more
T62	Temporal 1369 1389	within 8 weeks prior
T63	Procedure 1325 1333;1360 1368	Donation of blood
T64	Condition 1337 1341;1360 1368	loss of blood
T65	Condition 1402 1421	Significant illness
T66	Temporal 1422 1448	within the two weeks prior
T67	Condition 1465 1473;1485 1494	surgical condition
T68	Condition 1477 1494	medical condition
T70	Qualifier 1521 1596	alter the absorption, distribution, metabolism, or excretion of study drugs
T71	Temporal 1651 1658	History
T72	Condition 1662 1698	major gastrointestinal tract surgery
T73	Procedure 1707 1718	gastrectomy
T74	Procedure 1720 1737	gastroenterostomy
T75	Procedure 1742 1757	bowel resection
T77	Condition 1798 1824	inflammatory bowel disease
T78	Temporal 1825 1851	during the 12 months prior
T79	Temporal 1863 1879	Currently active
T80	Temporal 1760 1776	Currently active
T81	Temporal 1780 1797	previously active
T82	Condition 1880 1889	gastritis
T83	Condition 1891 1899	duodenal
T84	Condition 1903 1917	gastric ulcers
T85	Condition 1922 1938;1946 1954	gastrointestinal bleeding
T86	Condition 1939 1954	rectal bleeding
T87	Temporal 1955 1980	during the 3 months prior
T89	Condition 2009 2026	pancreatic injury
T90	Temporal 1998 2005	history
T91	Condition 2028 2040	pancreatitis
T92	Measurement 2065 2084	pancreatic function
T93	Value 2056 2064	impaired
T94	Condition 2065 2075;2085 2091	pancreatic injury
T95	Measurement 2117 2123	lipase
T96	Value 2108 2116	abnormal
T97	Measurement 2127 2134	amylase
T99	Condition 2147 2162	hepatic disease
T100	Temporal 2166 2173	history
T101	Condition 2177 2199	hepatic encephalopathy
T102	Condition 2214 2232	esophageal varices
T103	Condition 2250 2266	portocaval shunt
T104	Temporal 2239 2246	history
T105	Temporal 2203 2210	history
T107	Drug 2291 2305	cholestyramine
T108	Drug 2309 2327	cholestipol resins
T109	Temporal 2268 2275	Current
T110	Condition 2340 2356	immunocompromise
T111	Temporal 2329 2336	History
T112	Measurement 2379 2387	HIV test
T113	Value 2370 2378	positive
T114	Temporal 2397 2404	History
T115	Measurement 2419 2454;2470 2474	Hepatitis B surface antigen (HBsAg) test
T116	Measurement 2458 2474	Hepatitis C test
T117	Value 2410 2418	positive
T119	Temporal 2484 2491	History
T120	Condition 2495 2499;2511 2516	drug abuse
T121	Condition 2503 2516	alcohol abuse
T122	Temporal 2517 2543	within the 12 months prior
T124	Condition 2940 2947	allergy
T125	Drug 2951 2997	Angiotensin converting enzyme (ACE) inhibitors
T126	Drug 3008 3026	thiazide diuretics
T127	Drug 3036 3060	sulfonamide derived drug
T128	Condition 2875 2892	contraindications
T129	Drug 2900 2917	study medications
T130	Drug 3476 3485	Aliskiren
T131	Condition 3494 3502	Pregnant
T132	Condition 3506 3513	nursing
T133	Person 3514 3519	woman
T134	Competing_trial 1223 1249	any clinical investigation
T135	Reference_point 1274 1280	dosing
T136	Non-query-able 2556 2616	Persons directly involved in the execution of this protocol.
T137	Condition 2622 2631	condition
T138	Non-representable 2637 2671	in the opinion of the investigator
T139	Non-representable 2637 2654;2675 2703	in the opinion of the Novartis medical monitor
T140	Qualifier 2632 2636;2704 2747	that would jeopardize the evaluation of efficacy
T141	Qualifier 2632 2636;2704 2720;2751 2757	that would jeopardize safety
T144	Temporal 2759 2769	History of
T145	Observation 2770 2803	noncompliance to medical regimens
T146	Mood 2807 2823	unwillingness to
T147	Informed_consent 2824 2854	comply with the study protocol
T148	Temporal 2929 2939	history of
T149	Qualifier 3030 3035	other
T150	Condition 3078 3095	medical condition
T151	Condition 3066 3074;3086 3095	surgical condition
T152	Non-query-able 3103 3137	in the opinion of the investigator
T154	Drug 3339 3356	prescription drug
T155	Drug 3360 3393	over-the-counter (OTC) medication
T156	Qualifier 3403 3429	prohibited by the protocol
T158	Qualifier 3143 3215	place the patient at higher risk from his/her participation in the study
T159	Mood 3223 3257	likely to prevent the patient from
T160	Informed_consent 3258 3302	complying with the requirements of the study
T161	Negation 3233 3240	prevent
T162	Temporal 3445 3455	previously
T163	Competing_trial 3476 3491	Aliskiren study
T164	Qualifier 3522 3527	Other
T165	Qualifier 3528 3544	protocol-defined
T166	Non-representable 3522 3583	Other protocol-defined inclusion/exclusion criteria may apply
